PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)
$98.82 -5.265 (-5.0584%)
Analysed PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) News Sources
Is Protagonist Therapeutics (PTGX) Still Attractive After A 133% One-Year Share Price Surge
04-04-2026
yahoo.com
Takeda (TAK) Receives FDA Priority Review for Rusfertide in PV Treatment
03-04-2026
yahoo.com
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
28-03-2026
yahoo.com
Do Protagonist Therapeutics’ (PTGX) Derisked Drugs Have Blockbuster Potential?
27-03-2026
yahoo.com
Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE?
27-03-2026
yahoo.com
J&J's Pipeline Surge Sets Up Stronger Growth From New Drugs in 2026
26-03-2026
yahoo.com
US High Growth Tech Stocks to Watch Now
25-03-2026
yahoo.com
Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets
25-03-2026
yahoo.com
J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?
24-03-2026
yahoo.com
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
21-03-2026
fool.com
What is the current price of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The current price of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is $98.82.
PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) since the previous trading day is $-5.265.
PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) since the previous trading day is -5.0584%.
What is the most recent average sentiment score for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The most recent average sentiment score for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The most recent sentiment for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is .
SEC-8K** Filing Available For PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.